Lisa Pham

London

Journalist and writer. Currently a Bloomberg reporter in London via Hong Kong, New York, Sydney. Previously freelanced for IHT, NYT in Paris. Opinions my own.

Featured in: Favicon

bloomberg.com Favicon

uol.com.br (+1) Favicon

msn.com

nytimes.com Favicon

indiatimes.com Favicon

independent.co.uk Favicon

time.com

yahoo.com (+11) Favicon

hindustantimes.com Favicon

sfgate.com + 113 more

Articles

Why Some Plant-Based Burgers Are Healthier Than Others

5 days ago | bloomberg.com | Lisa Pham

Hi, it’s Lisa in London, where I’ve been wondering whether plant-based burgers can be considered healthy. But before we get to that... I love burgers, and in the past, there were occasions when I ate them multiple times a week. But in recent years I’ve focused on healthier eating, which has helped lessen some of my long Covid symptoms such as extreme fatigue. This has also meant that burgers are now only an occasional treat.
The King of Latin Trap Just Dropped His “SOFTEST” Album Yet?

1 week ago | thedepauw.com | Lisa Pham

Puerto Rican rapper, singer and producer Bad Bunny (Benito Antonio Martínez Ocasio) released his sixth studio album, “Debí Tirar Más Fotos (I Should’ve Taken More Photos),” on Jan. 5.
Fund Manager Beating 90% of Peers Sees More Stock Pain in Europe

2 weeks ago | bloomberg.com | Sagarika Jaisinghani |Lisa Pham

The rout in European equities is far from over as investors try to assess just how US President Donald Trump’s tariffs will hurt the global economy. That’s the view of Giulia Culot, senior portfolio manager at Sycomore Asset Management, whose €429 million ($471 million) European fund has beaten 90% of peers this year, according to data compiled by Bloomberg.
UBS Wealth Warns of Damage Tariffs Will Do to Energy Transition

2 weeks ago | news.bloomberglaw.com | Lisa Pham

The energy transition looks set to suffer a meaningful blow amid the continued decoupling of trade ties between the world’s two largest economies, according to analysts at UBS Group AG’s global wealth management arm. The deepening tariff war between America and China “cements challenges for US companies to import components key to decarbonization-related technologies,” UBS Wealth analysts including Amantia Muhedini and Tiffany Agard wrote in a note to clients dated April 4.
UBS Wealth Warns of Damage Tariffs Will Do to Energy Transition

2 weeks ago | financialpost.com | Lisa Pham

Share this Story : UBS Wealth Warns of Damage Tariffs Will Do to Energy TransitionThe energy transition looks set to suffer a meaningful blow amid the continued decoupling of trade ties between the world’s two largest economies, according to analysts at UBS Group AG’s global wealth management arm.
UBS Wealth Warns of Damage Tariffs Will Do to Energy Transition

2 weeks ago | bloomberg.com | Lisa Pham

The energy transition looks set to suffer a meaningful blow amid the continued decoupling of trade ties between the world’s two largest economies, according to analysts at UBS Group AG’s global wealth management arm. The deepening tariff war between America and China “cements challenges for US companies to import components key to decarbonization-related technologies,” UBS Wealth analysts including Amantia Muhedini and Tiffany Agard wrote in a note to clients dated April 4.
El peor mes de Novo Nordisk desde 2002 revela preocupaciones sobre el crecimiento

3 weeks ago | bloomberglinea.com | Lisa Pham

Bloomberg — A medida que las acciones de Novo Nordisk A/S (NVO) se encaminan hacia su peor mes en más de dos décadas, los días en que la farmacéutica danesa estaba valorada en más de US$600.000 millones se están convirtiendo en un recuerdo lejano. Los inversores han estado escrutando los datos semanales de prescripción en EE.UU.
Novo Nordisk perde valor de mercado e ações caem 27% com queda nas prescrições

3 weeks ago | bloomberglinea.com.br | Lisa Pham

Bloomberg — À medida que as ações da Novo Nordisk caminham para seu pior mês em mais de duas décadas, os dias em que a fabricante dinamarquesa de medicamentos era avaliada em mais de US$ 600 bilhões estão se tornando uma lembrança distante. Os investidores têm examinado os dados semanais de prescrição dos EUA em busca de sinais de um aumento no crescimento do Wegovy, medicamento para obesidade, e de como ele está se saindo em relação ao Zepbound, medicamento rival da Eli.
Novo Nordisk’s Worst Month Since 2002 Highlights Growth Concerns

3 weeks ago | bloomberg.com | Lisa Pham

Bloomberg Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world For Customers Bloomberg Anywhere Remote Login Software Updates Manage Products and Account Information Support Americas+1 212 318 2000 EMEA+44 20 7330 7500 Asia Pacific+65 6212 1000 Company About Careers Inclusion at Bloomberg Tech at Bloomberg Philanthropy Sustainability Bloomberg London...
Novo Nordisk’s Worst Month Since 2002 Highlights Growth Concerns

3 weeks ago | ca.finance.yahoo.com | Lisa Pham

(Bloomberg) -- As Novo Nordisk A/S shares head for their worst month in more than two decades, the days when the Danish drugmaker was valued at more than $600 billion are becoming a distant memory.